These findings suggest that it could also be used to screen putative natural co-factors to identify conditions that enable the conversion of wild-type of post-translationally modified forms of monomeric Tau into stable oligomeric forms or fibrillar structures that resemble those found in the brain of patients with Tauopathies (Fig. 10). Here, MAPT is linked to tauopathy.